Advancements in Therapy for Acute Lymphoblastic Leukemia: Blinatumomab
Lindsay Hladnik,1 PharmD, BCOP, Kristan Augustin,2 PharmD, BCOP, and Sean DeFrates,3 PharmD, BCOP
1Washington University Medical School, St. Louis, Missouri; 2Barnes-Jewish Hospital, St. Louis, Missouri; 3Northwestern Memorial Hospital, Chicago, Illinois
Authors’ disclosures of potential conflicts of interest are found at the end of this article.
Lindsay Hladnik, PharmD, BCOP, Alvin J. Siteman Cancer Center, Department of Medicine, Division of Medical Oncology, Washington University Medical School, 4921 Parkview Place, Suite 74, St. Louis, MO 63110. E-mail: email@example.com
doi: 10.6004/jadpro.2016.7.1.6 |
For access to the full length article, please sign in